Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1962 3
1963 1
1965 1
1967 1
1968 1
1970 1
1971 3
1972 4
1973 2
1974 9
1975 18
1976 24
1977 22
1978 30
1979 17
1980 32
1981 43
1982 46
1983 64
1984 53
1985 69
1986 80
1987 81
1988 103
1989 155
1990 176
1991 224
1992 225
1993 245
1994 213
1995 213
1996 239
1997 216
1998 260
1999 265
2000 268
2001 292
2002 294
2003 291
2004 323
2005 351
2006 354
2007 375
2008 380
2009 420
2010 429
2011 480
2012 502
2013 567
2014 550
2015 688
2016 779
2017 771
2018 825
2019 892
2020 982
2021 1105
2022 1208
2023 1137
2024 459

Text availability

Article attribute

Article type

Publication date

Search Results

15,982 results

Results by year

Filters applied: . Clear all
Page 1
PTS is activated by ATF4 and promotes lung adenocarcinoma development via the Wnt pathway.
Ma W, Wang C, Li R, Han Z, Jiang Y, Zhang X, Divisi D, Capobianco E, Zhang L, Dong W. Ma W, et al. Transl Lung Cancer Res. 2022 Sep;11(9):1912-1925. doi: 10.21037/tlcr-22-593. Transl Lung Cancer Res. 2022. PMID: 36248333 Free PMC article.
PTS was activated by ATF4, and up-regulation of ATF4 reversed the inhibitory effect of PTS silencing on LUAD cells. Silencing of PTS inhibited the Wnt pathway. Down-regulation of PTS inhibited tumor growth in mice. ...
PTS was activated by ATF4, and up-regulation of ATF4 reversed the inhibitory effect of PTS silencing on LUAD cells. Silencing …
The post-thrombotic syndrome.
Kahn SR. Kahn SR. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):413-418. doi: 10.1182/asheducation-2016.1.413. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913509 Free PMC article. Review.
This article discusses risk factors for PTS after DVT and available means to prevent and treat PTS, with a focus on new information in the field. After DVT, PTS will develop in 20% to 50% of patients, and severe PTS, including venous ulcers, will devel …
This article discusses risk factors for PTS after DVT and available means to prevent and treat PTS, with a focus on new inform …
The challenge of improving pterostilbene (PTS) solubility for solid and semi-solid dosage forms: The obtention of binary and ternary systems.
Waszczuk M, Bianchi SE, Pittol V, Martiny S, Delagustin MG, de Carvalho Meirelles G, Benes Raabe V, de Souza Barbosa F, Dos Santos Lacerda D, Araújo ASR, Bassani VL. Waszczuk M, et al. Int J Pharm. 2023 Mar 25;635:122736. doi: 10.1016/j.ijpharm.2023.122736. Epub 2023 Feb 19. Int J Pharm. 2023. PMID: 36804521
Dissolution tests revealed that after 120 min, in a buffer with a pH value of 1.2, only 43% of PTS dissolved. In contrast, 80% and 90% of PTS were dissolved from the PTS:BCD complex and PTS:BCD:HPMC ternary system, respectively. Moreover, the dissoluti …
Dissolution tests revealed that after 120 min, in a buffer with a pH value of 1.2, only 43% of PTS dissolved. In contrast, 80% and 90 …
PAPR reduction using SLM-PTS-CT hybrid PAPR method for optical NOMA waveform.
Kumar A, Rajagopal K, Alruwais N, Alshahrani HM, Mahgoub H, Othman KM. Kumar A, et al. Heliyon. 2023 Oct 14;9(10):e20901. doi: 10.1016/j.heliyon.2023.e20901. eCollection 2023 Oct. Heliyon. 2023. PMID: 37876455 Free PMC article.
In this article, we focus on optimising the SLM-PTS-CT (selective mapping, partial transmission sequence, circular transformation) hybrid method for optical non-orthogonal multiple access (O-NOMA) waveforms. ...The efficiency of the proposed method is analysed by estimatin …
In this article, we focus on optimising the SLM-PTS-CT (selective mapping, partial transmission sequence, circular transformation) hy …
Epidemiology of the post-thrombotic syndrome.
Galanaud JP, Monreal M, Kahn SR. Galanaud JP, et al. Thromb Res. 2018 Apr;164:100-109. doi: 10.1016/j.thromres.2017.07.026. Epub 2017 Jul 24. Thromb Res. 2018. PMID: 28844444 Review.
The reported prevalence of PTS differs widely among studies because of differences in study populations, tools used to assess PTS, and time interval between acute DVT and PTS assessment. ...This should enable identification of patient populations at high risk …
The reported prevalence of PTS differs widely among studies because of differences in study populations, tools used to assess PTS …
The post-thrombotic syndrome.
Kahn SR. Kahn SR. Hematology Am Soc Hematol Educ Program. 2010;2010:216-20. doi: 10.1182/asheducation-2010.1.216. Hematology Am Soc Hematol Educ Program. 2010. PMID: 21239797 Review.
The present review focuses on risk determinants of PTS after DVT and available means to prevent and treat PTS. More than one-third of patients with DVT will develop PTS, and 5% to 10% of patients develop severe PTS, which can manifest as venous ulcers. …
The present review focuses on risk determinants of PTS after DVT and available means to prevent and treat PTS. More than one-t …
External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis.
Rabinovich A, Gu CS, Vedantham S, Kearon C, Goldhaber SZ, Gornik HL, Kahn SR; ATTRACT Trial Investigators. Rabinovich A, et al. J Thromb Haemost. 2020 Jun;18(6):1381-1389. doi: 10.1111/jth.14791. Epub 2020 Apr 9. J Thromb Haemost. 2020. PMID: 32145144 Free PMC article.
The model's performance appeared to be better for the outcomes moderate to severe PTS and severe PTS (c-statistic 0.67; 95% CI 0.62-0.72 for moderate-severe PTS and 0.70; 0.64-0.77 for severe PTS). An updated model with age as an additional variable pe …
The model's performance appeared to be better for the outcomes moderate to severe PTS and severe PTS (c-statistic 0.67; 95% CI …
Optimized intensity-modulated type PTS-based PAPR reduction scheme for intensity-modulated direct-detection optical OFDM systems.
Ji R, Liu B, Ren J, Mao Y, Wu X, Wu Y, Zhao L, Sun T, Ullah R. Ji R, et al. Opt Express. 2023 Mar 13;31(6):10596-10616. doi: 10.1364/OE.473416. Opt Express. 2023. PMID: 37157603 Free article.
In this paper, an intensity-modulated type Partial Transmit Sequences (PTS) based scheme is proposed and applied to the intensity-modulated OFDM (IMDD-OFDM) system. The proposed intensity-modulated type PTS (IM-PTS) scheme ensures that the time-domain signal …
In this paper, an intensity-modulated type Partial Transmit Sequences (PTS) based scheme is proposed and applied to the intensity-mod …
Identification of PTS(Fru) as the major fructose uptake system of Clostridium acetobutylicum.
Voigt C, Bahl H, Fischer RJ. Voigt C, et al. Appl Microbiol Biotechnol. 2014 Aug;98(16):7161-72. doi: 10.1007/s00253-014-5809-1. Epub 2014 May 20. Appl Microbiol Biotechnol. 2014. PMID: 24841119
Here, we focus on three PTS which are expected to be involved in the uptake of fructose, PTS(Fru), PTS(ManI), and PTS(ManII). ...The inactivation of PTS(ManI) resulted in slower growth on mannose whereas the loss of PTS(ManII) revealed no …
Here, we focus on three PTS which are expected to be involved in the uptake of fructose, PTS(Fru), PTS(ManI), and PT …
Phyllodes Tumors of the Breast: A Literature Review.
Rayzah M. Rayzah M. Cureus. 2020 Sep 7;12(9):e10288. doi: 10.7759/cureus.10288. Cureus. 2020. PMID: 32923300 Free PMC article. Review.
The World Health Organization (WHO) has classified PTs histologically as benign, borderline, and malignant. PTs can be detected in all ages; however, the median age of presentation is 45 years. ...Surgery is considered the mainstay treatment for PTs of the br …
The World Health Organization (WHO) has classified PTs histologically as benign, borderline, and malignant. PTs can be detecte …
15,982 results
You have reached the last available page of results. Please see the User Guide for more information.